Cargando…
The role of tumour heterogeneity and clonal cooperativity in metastasis, immune evasion and clinical outcome
BACKGROUND: The advent of rapid and inexpensive sequencing technology allows scientists to decipher heterogeneity within primary tumours, between primary and metastatic sites, and between metastases. Charting the evolutionary history of individual tumours has revealed drivers of tumour heterogeneity...
Autores principales: | Caswell, Deborah R., Swanton, Charles |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514532/ https://www.ncbi.nlm.nih.gov/pubmed/28716075 http://dx.doi.org/10.1186/s12916-017-0900-y |
Ejemplares similares
-
Tumour heterogeneity and immune-modulation
por: Jamal-Hanjani, Mariam, et al.
Publicado: (2013) -
Emerging role of PTEN loss in evasion of the immune response to tumours
por: Vidotto, Thiago, et al.
Publicado: (2020) -
How Darwinian models inform therapeutic failure initiated by clonal heterogeneity in cancer medicine
por: Gerlinger, M, et al.
Publicado: (2010) -
Clonal selection versus clonal cooperation: the integrated perception of immune objects
por: Nataf, Serge
Publicado: (2016) -
Growth and Immune Evasion of Lymph Node Metastasis
por: Jones, Dennis, et al.
Publicado: (2018)